NephroGenex, Inc (NRX) Reports Q2 Loss of $0.61/Share

NephroGenex, Inc (NASDAQ: NRX) reported Q2 EPS of ($0.61), versus ($2.51) reported last year.

For earnings history and earnings-related data on NephroGenex, Inc (NRX) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Truist's 2Q26 Off-Cycle Earnings Preview for Cybersecurity Software: 'We favor RBRK and SAIL'